Cargando…
Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer
SIMPLE SUMMARY: In addition to its role in development and in the vascular and hematopoietic systems, ERG plays a central role in prostate cancer. Approximately 40–50% of prostate cancer cases are characterized by ERG gene fusions, which lead to ERG overexpression. Importantly, inhibition of ERG act...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909394/ https://www.ncbi.nlm.nih.gov/pubmed/35267426 http://dx.doi.org/10.3390/cancers14051118 |